The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Role of epithelial to mesenchymal transition in hepatocellular carcinoma
Open accessAbstract
The epithelial to mesenchymal transition (EMT) is a multistep biological process whereby epithelial cells change in plasticity by transient de-differentiation into a mesenchymal phenotype. EMT and its reversal, mesenchymal to epithelial transition (MET), essentially occur during embryogenetic morphogenesis and have been increasingly described in fibrosis and cancer during the last decade. In carcinoma progression, EMT plays a crucial role in early steps of metastasis when cells lose cell-cell contacts due to ablation of E-cadherin and acquire increased motility to spread into surrounding or distant tissues. Epithelial plasticity has become a hot issue in hepatocellular carcinoma (HCC), as strong inducers of EMT such as transforming growth factor-β are able to orchestrate both fibrogenesis and carcinogenesis, showing rising cytokine levels in cirrhosis and late stage HCC. In this review, we consider the significance of EMT-MET in malignant hepatocytes as well as changes in the plasticity of hepatic stellate cells for cellular heterogeneity of HCC, and further aim at explaining the current limiting insights into EMT by snapshot analyses of HCC tissues. Recent advances in the identification of clinically relevant mechanisms that impinge on important EMT-transcription factors, as well as on miRNAs causing EMT signatures and HCC progression are highlighted. In addition, we draw particular attention to framing EMT in the context of potential clinical relevance for HCC patients. We conclude that some aspects of EMT are still elusive and further studies are required to better link the clinical management of HCC with biomarkers and targeted therapies related to EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, T., Xie, J., Shen, C., Cheng, D., Shi, Y., Wu, Z., Deng, X., Chen, H., Shen, B., Peng, C., et al. (2016) · Oncogene · doi:10.1038/onc.2015.223 · Cited by 272
RetractedCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Zheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Yuan, J.-H., Yang, F., Wang, F., Ma, J.-Z., Guo, Y.-J., Tao, Q.-F., Liu, F., Pan, W., Wang, T.-T., Zhou, C.-C., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.010 · Cited by 1,515
Hoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238
Roessler, S., Jia, H.-L., Budhu, A., Forgues, M., Ye, Q.-H., Lee, J.-S., Thorgeirsson, S. S., Sun, Z., Tang, Z.-Y., Qin, L.-X., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2607 · Cited by 1,044
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
Nieto, M. A. (2013) · Science · doi:10.1126/science.1234850 · Cited by 967
Initial steps of metastasis: Cell invasion and endothelial transmigration
van Zijl, F., Krupitza, G., & Mikulits, W. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.05.002 · Cited by 883
Self-citationBudhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K. A., Kammula, U. S., Chen, Y., Qin, L.-X., Tang, Z.-Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.016 · Cited by 846
Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition
Zeisberg, M., Yang, C., Martino, M., Duncan, M. B., Rieder, F., Tanjore, H., & Kalluri, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700194200 · Cited by 839
TGF-β signaling and epithelial–mesenchymal transition in cancer progression
Katsuno, Y., Lamouille, S., & Derynck, R. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835b6371 · Cited by 786
The therapeutic promise of the cancer stem cell concept
Frank, N. Y., Schatton, T., & Frank, M. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41004 · Cited by 636
To differentiate or not — routes towards metastasis
Brabletz, T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3265 · Cited by 623
Santoro, A., Rimassa, L., Borbath, I., Daniele, B., Salvagni, S., Van Laethem, J. L., Van Vlierberghe, H., Trojan, J., Kolligs, F. T., Weiss, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70490-4 · Cited by 554
Origin of myofibroblasts in the fibrotic liver in mice
Iwaisako, K., Jiang, C., Zhang, M., Cong, M., Moore-Morris, T. J., Park, T. J., Liu, X., Xu, J., Wang, P., Paik, Y.-H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400062111 · Cited by 535
p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
Kim, T., Veronese, A., Pichiorri, F., Lee, T. J., Jeon, Y.-J., Volinia, S., Pineau, P., Marchio, A., Palatini, J., Suh, S.-S., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110235 · Cited by 514
Beyond E-cadherin: roles of other cadherin superfamily members in cancer
van Roy, F. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3647 · Cited by 475
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
Kriz, W., Kaissling, B., & Le Hir, M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44595 · Cited by 455
Kaposi-Novak, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27236 · Cited by 398
Xia, H., Ooi, L. L. P. J., & Hui, K. M. (2013) · Hepatology · doi:10.1002/hep.26369 · Cited by 378
Yang, M.-H., Chen, C.-L., Chau, G.-Y., Chiou, S.-H., Su, C.-W., Chou, T.-Y., Peng, W.-L., & Wu, J.-C. (2009) · Hepatology · doi:10.1002/hep.23221 · Cited by 359
Kim, H., Choi, G. H., Na, D. C., Ahn, E. Y., Kim, G. I., Lee, J. E., Cho, J. Y., Yoo, J. E., Choi, J. S., & Park, Y. N. (2011) · Hepatology · doi:10.1002/hep.24559 · Cited by 341
Omenetti, A., Porrello, A., Jung, Y., Yang, L., Popov, Y., Choi, S. S., Witek, R. P., Alpini, G., Venter, J., Vandongen, H. M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35875 · Cited by 341
Nath, A., Li, I., Roberts, L. R., & Chan, C. (2015) · Scientific Reports · doi:10.1038/srep14752 · Cited by 338
Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver
Österreicher, C. H., Penz-Österreicher, M., Grivennikov, S. I., Guma, M., Koltsova, E. K., Datz, C., Sasik, R., Hardiman, G., Karin, M., & Brenner, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017547108 · Cited by 337
Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
Taura, K., Miura, K., Iwaisako, K., Österreicher, C. H., Kodama, Y., Penz-Österreicher, M., & Brenner, D. A. (2010) · Hepatology · doi:10.1002/hep.23368 · Cited by 336
Coulouarn, C., Factor, V. M., & Thorgeirsson, S. S. (2008) · Hepatology · doi:10.1002/hep.22283 · Cited by 332
Metastasis: cancer cell’s escape from oxidative stress
Pani, G., Galeotti, T., & Chiarugi, P. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9225-4 · Cited by 313
Epithelial‐to‐mesenchymal transitions in the liver†
Choi, S. S., & Diehl, A. M. (2009) · Hepatology · doi:10.1002/hep.23196 · Cited by 307
Functional and genetic deconstruction of the cellular origin in liver cancer
Marquardt, J. U., Andersen, J. B., & Thorgeirsson, S. S. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4017 · Cited by 306
Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells
Miyoshi, A., Kitajima, Y., Sumi, K., Sato, K., Hagiwara, A., Koga, Y., & Miyazaki, K. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601685 · Cited by 284
Dooley, S., Hamzavi, J., Ciuclan, L., Godoy, P., Ilkavets, I., Ehnert, S., Ueberham, E., Gebhardt, R., Kanzler, S., Geier, A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.038 · Cited by 281
Li, J., Yang, B., Zhou, Q., Wu, Y., Shang, D., Guo, Y., Song, Z., Zheng, Q., & Xiong, J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt063 · Cited by 280
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
Govaere, O., Komuta, M., Berkers, J., Spee, B., Janssen, C., de Luca, F., Katoonizadeh, A., Wouters, J., van Kempen, L. C., Durnez, A., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-304351 · Cited by 273
The pathogenesis of idiopathic pulmonary fibrosis
Coward, W. R., Saini, G., & Jenkins, G. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810379801 · Cited by 272
Transforming Growth Factor-β as a Therapeutic Target in Hepatocellular Carcinoma
Giannelli, G., Villa, E., & Lahn, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0243 · Cited by 263
Self-citationGiannelli, G., Bergamini, C., Fransvea, E., Sgarra, C., & Antonaci, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.055 · Cited by 252
Self-citationScholten, D., Österreicher, C. H., Scholten, A., Iwaisako, K., Gu, G., Brenner, D. A., & Kisseleva, T. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.005 · Cited by 227
Ueki, T., Fujimoto, J., Suzuki, T., Yamamoto, H., & Okamoto, E. (1997) · Hepatology · doi:10.1002/hep.510250413 · Cited by 226
What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis
Iwaisako, K., Brenner, D. A., & Kisseleva, T. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07002.x · Cited by 219
Miyoshi, A., Kitajima, Y., Kido, S., Shimonishi, T., Matsuyama, S., Kitahara, K., & Miyazaki, K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602266 · Cited by 216
Chen, J., Chan, A. W. H., To, K.-F., Chen, W., Zhang, Z., Ren, J., Song, C., Cheung, Y.-S., Lai, P. B. S., Cheng, S.-H., et al. (2013) · Hepatology · doi:10.1002/hep.26278 · Cited by 214
Smoothened is a master regulator of adult liver repair
Michelotti, G. A., Xie, G., Swiderska, M., Choi, S. S., Karaca, G., Krüger, L., Premont, R., Yang, L., Syn, W.-K., Metzger, D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66904 · Cited by 208
Chu, A. S., Diaz, R., Hui, J.-J., Yanger, K., Zong, Y., Alpini, G., Stanger, B. Z., & Wells, R. G. (2011) · Hepatology · doi:10.1002/hep.24206 · Cited by 208
Ke, A., Shi, G., Zhou, J., Huang, X., Shi, Y., Ding, Z., Wang, X., Devbhandari, R. P., & Fan, J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.008 · Cited by 185
Gotzmann, J., Huber, H., Thallinger, C., Wolschek, M., Jansen, B., Schulte-Hermann, R., Beug, H., & Mikulits, W. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1189 · Cited by 185
Self-citationHepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge
van Zijl, F., Mair, M., Csiszar, A., Schneller, D., Zulehner, G., Huber, H., Eferl, R., Beug, H., Dolznig, H., & Mikulits, W. (2009) · Oncogene · doi:10.1038/onc.2009.253 · Cited by 175
Self-citationFischer, A. N. M., Fuchs, E., Mikula, M., Huber, H., Beug, H., & Mikulits, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210121 · Cited by 162
Self-citationZhang, J.-P., Zeng, C., Xu, L., Gong, J., Fang, J.-H., & Zhuang, S.-M. (2014) · Oncogene · doi:10.1038/onc.2013.369 · Cited by 160
Axl activates autocrine transforming growth factor‐β signaling in hepatocellular carcinoma
Reichl, P., Dengler, M., van Zijl, F., Huber, H., Führlinger, G., Reichel, C., Sieghart, W., Peck‐Radosavljevic, M., Grubinger, M., & Mikulits, W. (2014) · Hepatology · doi:10.1002/hep.27492 · Cited by 159
Self-citationLi, Y., Xu, S.-C., Li, J., Han, K.-Q., Pi, H.-F., Zheng, L., Zuo, G.-H., Huang, X.-B., Li, H.-Y., Zhao, H.-Z., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.347 · Cited by 159
Epithelial-to-Mesenchymal Transition of Murine Liver Tumor Cells Promotes Invasion†,‡
Ding, W., You, H., Dang, H. T., LeBlanc, F., Galicia, V. A., Lu, S. C.-L., Stiles, B. L., & Rountree, B. C. (2010) · Hepatology · doi:10.1002/hep.23748 · Cited by 158
Transforming Growth Factor-β1 Triggers Hepatocellular Carcinoma Invasiveness via α3β1 Integrin
Giannelli, G., Fransvea, E., Marinosci, F., Bergamini, C., Colucci, S. C., Schiraldi, O., & Antonaci, S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64170-3 · Cited by 158
Self-citationSulpice, L., Rayar, M., Desille, M., Turlin, B., Fautrel, A., Boucher, É., Llamas‐Gutierrez, F., Meunier, B., Boudjéma, K., Clément, B., et al. (2013) · Hepatology · doi:10.1002/hep.26577 · Cited by 157
Zhou, J., Zeng, Q., Wang, H., Zhang, B., Li, S., Nan, X., Cao, N., Fu, C., Yan, X., Jia, Y., et al. (2015) · Hepatology · doi:10.1002/hep.27887 · Cited by 156
Xia, L., Huang, W., Tian, D., Zhang, L., Qi, X., Chen, Z., Shang, X. C., Nie, Y., & Wu, K. (2013) · Hepatology · doi:10.1002/hep.26735 · Cited by 156
Xiao, S., Chang, R., Yang, M., Lei, X., Liu, X., Gao, W., Xiao, J., & Yang, L. (2015) · Hepatology · doi:10.1002/hep.28417 · Cited by 152
Govaere, O., Wouters, J., Petz, M., Vandewynckel, Y., den Eynde, K. V., den broeck, A. V., Verhulst, S., Dollé, L., Gremeaux, L., Ceulemans, A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.011 · Cited by 144
Self-citationFu, J., Chen, Y., Cao, J., Luo, T., Qian, Y., Yang, W. K., Ren, Y., Su, B., Cao, G., Yang, Y., et al. (2010) · Hepatology · doi:10.1002/hep.24015 · Cited by 134
Ogunwobi, O. O., & Liu, C. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9404-x · Cited by 131
Wang, R., Chen, L., Chen, H., Hu, L., Li, L., Sun, H., Jiang, F., Zhao, J., Liu, G., Tang, J. P., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.009 · Cited by 123
Zhai, X., Zhu, H., Wang, W., Zhang, S., Zhang, Y., & Mao, G. (2014) · Medical Oncology · doi:10.1007/s12032-014-0970-z · Cited by 123
Origin of myofibroblasts in liver fibrosis
Brenner, D. A., Kisseleva, T., Scholten, D., Paik, Y. H., Iwaisako, K., Inokuchi, S., Schnabl, B., Seki, E., Minicis, S. D., Oesterreicher, C., et al. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s17 · Cited by 122
miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma
Tao, Z., Wan, J.-L., Zeng, L., Xie, L., Sun, H., Qin, L., Wang, L., Zhou, J., Ren, Z., Li, Y., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20120153 · Cited by 120
Fernando, J., Malfettone, A., Cepeda, E. B., Vilarrasa‐Blasi, R., Bertrán, E., Raimondi, G., Fabra, À., Alvarez, A. M., Fernández‐Salguero, P. M., Fernández‐Rodríguez, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29097 · Cited by 119
Self-citationMyofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy
Swiderska-Syn, M., Syn, W. K., Xie, G., Krüger, L., Machado, M. V., Karaca, G., Michelotti, G. A., Choi, S. S., Premont, R. T., & Diehl, A. M. (2014) · Gut · doi:10.1136/gutjnl-2013-305962 · Cited by 115
Prange, W., Breuhahn, K., Fischer, F. F., Zilkens, C., Pietsch, T., Petmecky, K., Eilers, R., Dienes, H., & Schirmacher, P. (2003) · The Journal of Pathology · doi:10.1002/path.1448 · Cited by 112
Xia, H., Chen, J., Shi, M., Gao, H., Sekar, K., Seshachalam, V. P., Ooi, L. L., & Hui, K. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.005 · Cited by 105
Epithelial-mesenchymal transitions and hepatocarcinogenesis
Jou, J. H., & Diehl, A. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42615 · Cited by 105
Evidence for and against epithelial-to-mesenchymal transition in the liver
Xie, G., & Diehl, A. M. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00289.2013 · Cited by 105
Zhao, H., Lv, F., Liang, G., Huang, X., Wu, G., Zhang, W., Yu, L., Shi, L., & Teng, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.6185 · Cited by 105
Dituri, F., Mazzocca, A., Peidrò, F. J., Papappicco, P., Fabregat, I., Santis, F. D., Paradiso, A., Sabbà, C., & Giannelli, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067109 · Cited by 103
Self-citationZhou, Z., Dai, Z., Zhou, S., Hu, Z., Chen, Q., Zhao, Y., Shi, Y., Gao, Q., Wu, W., Qiu, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2509 · Cited by 103
Caja, L., Bertrán, E., Campbell, J. S., Fausto, N., & Fabregat, I. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22439 · Cited by 101
TGF-β in Epithelial to Mesenchymal Transition and Metastasis of Liver Carcinoma
Reichl, P., Haider, C., Grubinger, M., & Mikulits, W. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802430477 · Cited by 101
Self-citationDefining the role of laminin-332 in carcinoma
Guess, C. M., & Quaranta, V. (2009) · Matrix Biology · doi:10.1016/j.matbio.2009.07.008 · Cited by 98
Wang, Y.-P., Yu, G., Lee, M.-J., Lee, S.-Y., Chu, I., Leem, S., & Kim, D. (2013) · Hepatology · doi:10.1002/hep.26467 · Cited by 97
Giannelli, G., Fransvea, E., Bergamini, C., Marinosci, F., & Antonaci, S. (2003) · PubMed · Cited by 97
Self-citationEpithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?
Pinzani, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.001 · Cited by 86 · cited 1×
“This allows hepatocyte derivatives to move and escape from damage and apoptosis under more benign conditions, and finally to restore the epithelial phenotype through a MET-like process [28].”
BackgroundYang, M., Li, S.-N., Anjum, K. M., Gui, L., Zhu, S., Liu, J., Chen, J., Liu, Q., Ye, G.-D., Wang, W., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.135053 · Cited by 86
Hepatic stellate cells stimulate HCC cell migration via laminin-5 production
Santamato, A., Fransvea, E., Dituri, F., Caligiuri, A., Quaranta, M., Niimi, T., Pinzani, M., Antonaci, S., & Giannelli, G. (2011) · Clinical Science · doi:10.1042/cs20110002 · Cited by 79
Self-citationHuang, J., Zhang, K., Chen, D., Chen, J., Feng, B., Song, H., Chen, Y., Zhu, Z., Lü, L., De, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4317 · Cited by 77
Yamada, S., OKUMURA, N., Wei, L., Fuchs, B. C., Fujii, T., Sugimoto, H., Nomoto, S., Takeda, S., Tanabe, K. K., & Kodera, Y. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3779-2 · Cited by 77
Tsuchiya, K., Komuta, M., Yasui, Y., Tamaki, N., Hosokawa, T., Ueda, K., Kuzuya, T., Itakura, J., Nakanishi, H., Takahashi, Y., et al. (2011) · Oncology · doi:10.1159/000328448 · Cited by 74
Bergamini, C., Sgarra, C., Trerotoli, P., Lupo, L., Azzariti, A., Antonaci, S., & Giannelli, G. (2007) · Hepatology · doi:10.1002/hep.21936 · Cited by 72
Self-citationPedrozo, H. A., Schwartz, Z., Robinson, M., Gómez, R., Dean, D. D., Bonewald, L. F., & Boyan, B. D. (1999) · Endocrinology · doi:10.1210/endo.140.12.7224 · Cited by 69
Chen, S., Liu, B., Xu, J., Pei, X., Liao, Y.-J., Yuan, F., & Zheng, F. (2015) · BMC Cancer · doi:10.1186/s12885-015-1738-3 · Cited by 68
Mima, K., Hayashi, H., Kuroki, H., Nakagawa, S., OKABE, H., Chikamoto, A., Watanabe, M., Beppu, T., & Baba, H. (2012) · Oncology Letters · doi:10.3892/ol.2012.954 · Cited by 66
SHP-1 is a negative regulator of epithelial–mesenchymal transition in hepatocellular carcinoma
Fan, L.-C., Shiau, C.-W., Tai, W.-T., Hung, M.-H., Chu, P.-Y., Hsieh, F.-S., Lin, H., Yu, H., & Chen, K.-F. (2015) · Oncogene · doi:10.1038/onc.2014.445 · Cited by 66
Petz, M., Them, N. C. C., Huber, H., & Mikulits, W. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks760 · Cited by 61
Self-citationEGFR and VEGFR as potential target for biological therapies in HCC cells
Giannelli, G., Sgarra, C., Porcelli, L., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.12.001 · Cited by 57
Self-citationWang, R., Li, Y., Hou, Y., Yang, Q., Chen, S., Wang, X., Wang, Z., Yang, Y. F., Chen, C., Wang, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3193 · Cited by 56
Wang, Z., Gao, Q., Shi, J.-Y., Guo, W., Yang, L., Liu, X., Liu, L., Ma, L., Duan, M., Zhao, Y., et al. (2015) · Hepatology · doi:10.1002/hep.27911 · Cited by 56
Tanaka, S., Shiraha, H., Nakanishi, Y., Nishina, S., Matsubara, M., Horiguchi, S., Takaoka, N., Iwamuro, M., Kataoka, J., Kuwaki, K., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27575 · Cited by 55
Zhu, Y., Cheng, Y., Guo, Y., Chen, J., Chen, F., Luo, R., & Li, A. (2015) · Oncotarget · doi:10.18632/oncotarget.6633 · Cited by 51
Kim, J., Hong, S. J., Park, J. Y., Park, J. H., Yu, Y. S., Park, S. Y., Lim, E. K., Choi, K. Y., Lee, E. K., Paik, S. S., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01536.x · Cited by 49
Liu, L., Ren, Z., Shen, Y., Zhu, X., Zhang, W., Xiong, W., Qin, Y., & Tang, Z. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01363.x · Cited by 48
Disregulation of E-cadherin in transgenic mouse models of liver cancer
Calvisi, D. F., Ladu, S., Conner, E. A., Factor, V. M., & Thorgeirsson, S. S. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700147 · Cited by 46
Fransvea, E., Mazzocca, A., Santamato, A., Azzariti, A., Antonaci, S., & Giannelli, G. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1459-x · Cited by 44
Self-citationZhu, M., Yin, F., Fan, X., Jing, W., Chen, R., Liu, L., Zhang, L., Liu, Y., Liang, Y., Bu, F., et al. (2014) · Oncogene · doi:10.1038/onc.2014.73 · Cited by 39
Dituri, F., Mazzocca, A., Fernando, J., Papappicco, P., Fabregat, I., Santis, F. D., Paradiso, A., Sabbà, C., & Giannelli, G. (2013) · PLoS ONE · doi:10.1371/annotation/c943a596-3965-4a5b-a27c-55c16685ea32 · Cited by 37
Self-citationCaja, L., Kahata, K., & Moustakas, A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802430459 · Cited by 23
Dituri, F., Serio, G., Filannino, D., Mascolo, A., Sacco, R., Villa, E., & Giannelli, G. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.029 · Cited by 22
Self-citation
Cited by
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Fabregat, I., & Caballero-Díaz, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00357 · Cited by 351
Chen, L., Guo, P., He, Y., Chen, Z., Chen, L., Luo, Y., Qi, L., Liu, Y., Wu, Q., Cui, Y., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0534-9 · Cited by 253
Bárcena‐Varela, M., Caruso, S., Llerena, S., Álvarez‐Sola, G., Uriarte, I., Latasa, M. U., Urtasun, R., Rebouissou, S., Alvarez, L., Jimenez, M., et al. (2019) · Hepatology · doi:10.1002/hep.30168 · Cited by 130
Ribera, J., Pauta, M., Melgar-Lesmes, P., Córdoba, B., Bosch, A., Calvo, M., Rodrigo-Torres, D., Sancho-Bru, P., Mira, A., Jiménez, W., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00428.2016 · Cited by 64
Han, S., Xue, L., Wei, Y., Yong, T., Jia, W., Qi, Y., Luo, Y., Liang, J., Wen, J., Bie, N., et al. (2023) · Advanced Science · doi:10.1002/advs.202207080 · Cited by 24
Metadata
- Authors
- Giannelli, G., Koudelkova, P., Dituri, F., & Mikulits, W.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 65
- Issue
- 4
- Pages
- 798-808
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2407812106
- Cited by
- 615
- References
- 109
- FWCI
- 20.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.